Search
Chemomab Therapeutics Ltd
CMMBAdd to Watchlist
1.410USD
+0.050+3.68%
Close 07-24 16:00（ET）Quotes delayed by 15 min
40.61MMarket Cap
8.09P/E TTM
CMMB Financials
See Chemomab Therapeutics Ltd's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Chemomab Therapeutics Ltd Earnings Date
Latest Release
May 14, 2026
EPS / Forecast
--/-0.16
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.41
88.65%
Analyst Rating
STRONG BUY
2026/07/27
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Chemomab Therapeutics Ltd?
According to Chemomab Therapeutics Ltd's FY2025 earnings report, its current assets were 13.43M, with a year-on-year change of -16.30.
What are the total assets of Chemomab Therapeutics Ltd?
According to Chemomab Therapeutics Ltd's FY2025 earnings report, its total assets of Chemomab Therapeutics Ltd were 13.81M, with a year-on-year change of -18.58.
What are the total liabilities of Chemomab Therapeutics Ltd?
According to Chemomab Therapeutics Ltd's FY2025 earnings report, its total liabilities of Chemomab Therapeutics Ltd were 1.48M, with a year-on-year change of -56.87.
What is the total equity of Chemomab Therapeutics Ltd?
According to Chemomab Therapeutics Ltd's FY2025 earnings report, its total equity of Chemomab Therapeutics Ltd was 12.33M, with a year-on-year change of -8.89.
What is the net operating income of Chemomab Therapeutics Ltd?
According to Chemomab Therapeutics Ltd's FY2025 earnings report, its net operating income of Chemomab Therapeutics Ltd was -9.57M, with a year-on-year change of 35.09.
What is the net investment of Chemomab Therapeutics Ltd?
According to Chemomab Therapeutics Ltd's FY2025 earnings report, its net investment of Chemomab Therapeutics Ltd was 5.39M, with a year-on-year change of 134.65.
What is the net financing of Chemomab Therapeutics Ltd?
According to Chemomab Therapeutics Ltd's FY2025 earnings report, its net financing of Chemomab Therapeutics Ltd was 7.16M, with a year-on-year change of -27.47.
What is the Earnings Per Share (EPS) of Chemomab Therapeutics Ltd?
According to Chemomab Therapeutics Ltd's FY2025 earnings report, its Earnings Per Share (EPS) was -1.41, with a year-on-year change of 88.65.
What is the net income of Chemomab Therapeutics Ltd?
According to Chemomab Therapeutics Ltd's FY2025 earnings report, its net income was -8.99M, with a year-on-year change of 35.50.
What is the Return on Equity (ROE) of Chemomab Therapeutics Ltd?
According to Chemomab Therapeutics Ltd's FY2025 earnings report, its Return on Equity (ROE) was -69.54, with a year-on-year change of 23.87.
What is the Return on Assets (ROA) of Chemomab Therapeutics Ltd?
According to Chemomab Therapeutics Ltd's FY2025 earnings report, its Return on Assets (ROA) was -58.45, with a year-on-year change of 18.02.
What is the operating profit of Chemomab Therapeutics Ltd?
According to Chemomab Therapeutics Ltd's FY2025 earnings report, its operating profit was -9.57M, with a year-on-year change of 35.09.